Navigation Links
Letter From Carl Icahn to Amylin Pharmaceutical, Inc.
Date:4/15/2009

urne and the Icahn group from having any constructive dialogue with each other.

Having two major stockholders both independently decide to run a proxy fight against the same board is rare -- it dramatically shows how stockholders have lost faith in the Amylin's board's ability to run the company. Additionally, it is also almost unheard of, at the same time, to have a co-founder and director of the company resign and express his displeasure with your stewardship.

How could it not be in the best interest of Amylin and its stockholders to allow a dialogue to begin among Eastbourne, the Icahn group and the company? We could immediately enter into discussions on how to end two "debilitating" proxy fights, and more importantly, how to enhance stockholder value in other ways. With all due respect, Amylin, under your stewardship, has made many grievous mistakes. For example, Amylin never should have undertaken to spend enormous amounts of money to maintain a large commercial operation in primary care diabetes sales -- an absurd commercial effort for a small biotech company. (Had we been on the board of Amylin when its deal with Lilly was consummated, we would have fought for a royalty paying arrangement with an option to co-promote Byetta -- an arrangement that could possibly have caused Amylin to have positive cash flow today.) SG&A has been made too high at Amylin in part as a result of the primary-care sales force, and in part because management and the board allowed it to happen. Amylin's SG&A is approximately 47% of sales compared with other similar biotech companies(1) whose median SG&A is approximately 22%. As directors, my nominees would seek to have Amylin renegotiate with Lilly to change their commercial agreement. In addition, we believe that the company should engage experts to advise on how to reduce the amount of money being wasted at Amylin. However, at the risk of being facetious, I wo
'/>"/>

SOURCE Carl Icahn
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. ULURU Inc. Signs Offer Letter to Acquire York Pharma plc
2. Immtech Receives Listing Determination Letter
3. Go Healthy Announces Receipt of Letter of Interest to Fund Distribution, Production, Packaging, Concept Stores and Bottling Facilities
4. SETO Holdings, Inc. Signs Letter of Intent to Dispose of all its Existing Businesses and Acquire Advanced Hearing Centers, Inc.; New Management to be Installed.
5. Runaway Health Care Costs: 12 Ways You Can Rein Them in, from the Harvard Health Letter
6. FDA Warning Letter to Genzyme Related to the Allston Manufacturing Facility
7. MedClean Technologies Inc. CEO Publishes Letter to Shareholders
8. The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders
9. Major Shareholders Criticize Enzon Pharmaceuticals Management Team in Open Letter
10. Blunt Marks Anniversary of Roe v. Wade, Signs Letter in Defense of Pro-Life Legislation
11. January 2009 Mayo Clinic Health Letter Highlights Improved PSA Tests, Dry Eyes and Colds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... semen is naturally colonized by bacteria, and a new study ... both HIV transmission and levels in infected men. U.S. ... play a role in local inflammation and in the production ... to possible targets for reducing transmission of the AIDS-causing virus. ... changes in HIV levels, and the researchers say more research ...
(Date:7/24/2014)... the body,s own immune system play a role in ... chronic epilepsy, Alzheimer,s dementia and concussions? Cleveland Clinic researchers ... PLOS ONE . , The study focuses on ... serves as a biomarker for brain damage. Normally, S100B ... However, following a brain injury, it can leak through ...
(Date:7/24/2014)... to transform into an aggressive form of cancer, are ... the metastasis or, even better, prevent their formation would ... Researchers at Universit catholique de Louvain (Belgium) successfully performed ... mice. The results of their study are published ... Cell Reports . , The work by Professor Pierre ...
(Date:7/24/2014)... prenatal ultrasounds uncover antenatal hydronephrosis, or enlarged kidneys, ... United States. Many children with this abnormality are ... few years of life with the hopes of ... recently, however, little evidence existed as to the ... and inconvenience for families. But a study published ...
(Date:7/24/2014)... The Biofeedback Federation of Europe is ... game development company Zukor Interactive. The agreement provides ... Zukor's Grind , a next-generation feedback game ... and international markets. , Zukor's Grind is a ... as a biofeedback/neurofeedback training tool. Typical training provides ...
Breaking Medicine News(10 mins):Health News:Bacteria in Semen May Affect HIV Transmission, Levels: Study 2Health News:Immune response may cause harm in brain injuries, disorders 2Health News:A world first: Researchers identify a treatment that prevents tumor metastasis 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 3Health News:Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive 2Health News:Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive 3
... chromosome lineage reveals farming influence , TUESDAY, Jan. 19 (HealthDay ... farmers who migrated from the Near East 10,000 years ago, ... Y chromosome, which is passed from father to son. , ... by about 110 million men -- it follows a gradient ...
... A.M. , Justin Herman Plaza , Market ... www.walkforlifewc.c o m , Speakers and organizers are available ... A woman who walked away from her job as a clinic director at ... on exposing abuses in the abortion industry will speak at the 6th Annual Walk ...
... , MIDLAND, ... adopt lifelong healthy behaviors with Health Enhancement Systems, ( ... The online program, 5 on 5 ( www.5on5.com ... habits wrapped in an exciting basketball tournament format. Participants form teams of ...
... , STRATHAM, N.H. ... world,s leading producer of premium chocolate, announces it is accepting nominations for ... the second year, Lindt will honor ordinary individuals who are extraordinary champions ... Lindt Unsung Heroes of Autism program is part of Lindt,s partnership with ...
... ,greater than, problems, study suggests , TUESDAY, Jan. 19 ... math? , A German team of neurobiologists has found ... using specific brain cells dedicated to the comprehension of ... insight into the neurology behind human ability to comprehend ...
... , TAMPA, Fla. , Jan. 19 ... Preventative Task Force (USPTF), the Obesity Action Coalition (OAC) is ... coverage of the recommended childhood obesity treatments. , The recommendations ... in moderate to intensive programs helps children affected by obesity ...
Cached Medicine News:Health News:6th Annual Walk for Life West Coast Saturday, January 23, 2010 2Health News:Corporate Teams Score Points for Healthy Eating 2Health News:Corporate Teams Score Points for Healthy Eating 3Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 2Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 3Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 4Health News:Monkey Brain 'Hardwired' for Simple Math 2Health News:Monkey Brain 'Hardwired' for Simple Math 3Health News:Obesity Action Coalition Calls on Insurers and Employers to Increase Access to Childhood Obesity Treatments Based on Recent United States Preventative Task Force Recommendations 2
(Date:7/24/2014)... , July 24, 2014 Decision Resources ... in the EU5 countries ( France , ... , Spain and the ... view of the first once-daily long-acting beta2 agonist/inhaled corticosteroid ... robust uptake of Relvar as a first-line LABA/ICS FDC ...
(Date:7/24/2014)... BOSTON , July 24, 2014 Boston ... on Tomorrow (#PedInno14), will feature an "Innovation Tank" ... innovators an opportunity to pitch their business or product ... of funding and feedback on how to accelerate the ... competition, occurring the morning of Friday, October 31, will ...
(Date:7/24/2014)... IRVING, Texas , July 24, 2014 /PRNewswire/ ... in the cardiovascular market that could impact patient ... Spring 2014 CV Watch , "Innovations in ... report provides hospitals with guidance and details on ... serve patient needs and understand how these options ...
Breaking Medicine Technology:Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 2New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 3
... 16 The following is being,issued by Trust ... call to discuss a new report from the,American ... Health (TFAH),"Pandemic Influenza: Warning, Children At-Risk." The report ... for children during a possible,pandemic flu outbreak and ...
... Oct. 16 Boston Scientific,Corporation (NYSE: ... the Company,s major,events and press announcements at ... Cardiovascular Therapeutics (TCT),scientific symposium, which runs from ... Boston Scientific will be announcing a ...
Cached Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 3Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 4Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 5Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 6Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 7
Gently curved shaft with blunt angled tip is ideal for chopping the lens during anterior chamber phacoemulsification....
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique to be used in left hand. Round knurled handle....
Flat 7 mm wide hook. Flat serrated handle with polished finish. Overall length: 5.1 inches....
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
Medicine Products: